Cargando…

Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology

Inter-patient molecular heterogeneity is the major declared driver of an expanding variety of anticancer drugs and personalizing their prescriptions. Here, we compared interpatient molecular heterogeneities of tumors and repertoires of drugs or their molecular targets currently in use in clinical on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zolotovskaia, Marianna A., Sorokin, Maxim I., Petrov, Ivan V., Poddubskaya, Elena V., Moiseev, Alexey A., Sekacheva, Marina I., Borisov, Nicolas M., Tkachev, Victor S., Garazha, Andrew V., Kaprin, Andrey D., Shegay, Peter V., Giese, Alf, Kim, Ella, Roumiantsev, Sergey A., Buzdin, Anton A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084891/ https://www.ncbi.nlm.nih.gov/pubmed/32111026 http://dx.doi.org/10.3390/ijms21051580

Ejemplares similares

OncoboxPD: human 51 672 molecular pathways database with tools for activity calculating and visualization
por: Zolotovskaia, Marianna A., et al.
Publicado: (2022)

Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers
por: Zolotovskaia, Marianna A., et al.
Publicado: (2019)

Mutation Enrichment and Transcriptomic Activation Signatures of 419 Molecular Pathways in Cancer
por: Zolotovskaia, Marianna A., et al.
Publicado: (2020)

Algorithmically Reconstructed Molecular Pathways as the New Generation of Prognostic Molecular Biomarkers in Human Solid Cancers
por: Zolotovskaia, Marianna, et al.
Publicado: (2023)

RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer
por: Sorokin, Maxim, et al.
Publicado: (2020)

Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs
por: Zolotovskaia, Marianna A., et al.
Publicado: (2019)

Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments
por: Borisov, Nicolas, et al.
Publicado: (2020)

Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data
por: Sorokin, Maxim, et al.
Publicado: (2022)

Algorithmic Annotation of Functional Roles for Components of 3,044 Human Molecular Pathways
por: Sorokin, Maxim, et al.
Publicado: (2021)

Flexible Data Trimming Improves Performance of Global Machine Learning Methods in Omics-Based Personalized Oncology
por: Tkachev, Victor, et al.
Publicado: (2020)

Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas
por: Zolotovskaia, Marianna, et al.
Publicado: (2021)

Large-scale assessment of pros and cons of autopsy-derived or tumor-matched tissues as the norms for gene expression analysis in cancers
por: Sorokin, Maksim, et al.
Publicado: (2023)

Next-Generation Grade and Survival Expression Biomarkers of Human Gliomas Based on Algorithmically Reconstructed Molecular Pathways
por: Zolotovskaia, Marianna A., et al.
Publicado: (2022)

High-Throughput Mutation Data Now Complement Transcriptomic Profiling: Advances in Molecular Pathway Activation Analysis Approach in Cancer Biology
por: Buzdin, Anton, et al.
Publicado: (2019)

Shambhala: a platform-agnostic data harmonizer for gene expression data
por: Borisov, Nicolas, et al.
Publicado: (2019)

Case of multifocal glioblastoma with four fusion transcripts of ALK, FGFR2, NTRK2, and NTRK3 genes stresses the need for tumor tissue multisampling for transcriptomic analysis
por: Samii, Amir, et al.
Publicado: (2021)

FLOating-Window Projective Separator (FloWPS): A Data Trimming Tool for Support Vector Machines (SVM) to Improve Robustness of the Classifier
por: Tkachev, Victor, et al.
Publicado: (2019)

Profiling of Human Molecular Pathways Affected by Retrotransposons at the Level of Regulation by Transcription Factor Proteins
por: Nikitin, Daniil, et al.
Publicado: (2018)

Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways
por: Kamashev, Dmitri, et al.
Publicado: (2023)

A systematic experimental evaluation of microRNA markers of human bladder cancer
por: Zabolotneva, Anastasia A., et al.
Publicado: (2013)

Characteristic patterns of microRNA expression in human bladder cancer
por: Zabolotneva, Anastasia A., et al.
Publicado: (2013)

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas
por: Petrov, Ivan, et al.
Publicado: (2017)

MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways
por: Artcibasova, Alina V., et al.
Publicado: (2016)

Distinct Traits of Structural and Regulatory Evolutional Conservation of Human Genes with Specific Focus on Major Cancer Molecular Pathways
por: Zakharova, Galina, et al.
Publicado: (2023)

Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells
por: Petrov, Ivan, et al.
Publicado: (2016)

Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data
por: Rabushko, Elizaveta, et al.
Publicado: (2022)

RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
por: Sorokin, Maxim, et al.
Publicado: (2020)

Uniformly shaped harmonization combines human transcriptomic data from different platforms while retaining their biological properties and differential gene expression patterns
por: Borisov, Nicolas, et al.
Publicado: (2023)

Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression Data
por: Sorokin, Maxim, et al.
Publicado: (2018)

Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability
por: Sorokin, Maksim, et al.
Publicado: (2021)

RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples
por: Sorokin, Maxim, et al.
Publicado: (2021)

Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution
por: Nikitin, Daniil, et al.
Publicado: (2019)

Correction: Nikitin, D., et al. Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution. Cells 2019, 8, 130
por: Nikitin, Daniil, et al.
Publicado: (2019)

Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma
por: Kim, Ella L., et al.
Publicado: (2020)

Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs
por: Zhavoronkov, Alex, et al.
Publicado: (2014)

Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles
por: Borisov, Nicolas, et al.
Publicado: (2021)

Friends-Enemies: Endogenous Retroviruses Are Major Transcriptional Regulators of Human DNA
por: Buzdin, Anton A., et al.
Publicado: (2017)

New bioinformatic tool for quick identification of functionally relevant endogenous retroviral inserts in human genome
por: Garazha, Andrew, et al.
Publicado: (2015)

Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer
por: Gudkov, Alexander, et al.
Publicado: (2022)

The Role of the Metabolism of Zinc and Manganese Ions in Human Cancerogenesis
por: Rozenberg, Julian Markovich, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_14q5l5v4vu0s6gks2iitoi2e5i